Perceptive Advisors LLC C4 Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.06 - $26.46 $6.66 Million - $34.8 Million	-1,316,492 Reduced 63.21%	766,231 $5.78 Million
Q1 2022 May 16, 2022	SELL	$19.99 - $33.23 $2.52 Million - $4.19 Million	-126,190 Reduced 5.71%	2,082,723 $50.5 Million
Q4 2021 Feb 14, 2022	SELL	$29.39 - $46.86 $1.46 Million - $2.33 Million	-49,653 Reduced 2.2%	2,208,913 $71.1 Million
Q2 2021 Aug 16, 2021	SELL	$30.39 - $42.18 $27.4 Million - $38 Million	-900,000 Reduced 28.49%	2,258,566 $85.5 Million
Q4 2020 Feb 16, 2021	BUY	$22.8 - $37.05 $72 Million - $117 Million	3,158,566 New	3,158,566 $105 Million

126

63M

651K

115K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $104M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.